The invention is related to anti-viral compounds of formula (Ic):E-V-Z-P-M-A-A-M-P-Z-V-E (Ic)or a pharmaceutically acceptable salt thereof, wherein:each E is methoxycarbonylamino；each V is V0；each Z is -C(=O)-；each P iseach M is independently imidazolyl or benzimidazolyl；compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
